Science Explorer Interactive view Map

Abzena (United Kingdom)

Research works
25
▲ 149% vs 2013–17
Citations
533
21.6 per fractional work
Top-10% rate
6.6%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: Abzena (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.60× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.48× its world share, 1 worksImmunology and Micro…Chemistry: 7.39× its world share, 1 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceMathematics: 0.12× its world share, 0 worksMathematicsMedicine: 2.61× its world share, 6 worksMedicineEconomics, Econometrics and Finance: 0.19× its world share, 0 worksEconomics, Econometr…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.

Which keywords describe research at Abzena (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Chemotherapy, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Monoclonal Antibody and Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Glycosylation4▲ 65×3 topics
  2. Monoclonal Antibodies3▲ 95×3 topics
  3. Chemotherapy3▲ 18×8 topics
  4. Therapeutic Antibodies3▲ 94×2 topics
  5. Antibody Engineering3▲ 115×1 topic
  6. Fc Receptors3▲ 115×1 topic
  7. Monoclonal Antibody2▲ 145×2 topics
  8. Breast Cancer2▲ 33×4 topics
  9. Cancer2▲ 6.5×10 topics
  10. Cancer Therapy2▲ 14×7 topics
  11. HER22▲ 266×1 topic
  12. Metastatic2▲ 130×2 topics
  13. Trastuzumab2▲ 189×1 topic
  14. Tumor Microenvironment2▲ 23×4 topics
  15. Quantitative Analysis2▲ 37×2 topics
  16. Homologous Recombination1▲ 82×2 topics
  17. Cell Death1▲ 25×3 topics
  18. Drug Discovery1▲ 13×4 topics
  19. PET Imaging1▲ 22×3 topics
  20. Precision Medicine1▲ 16×3 topics
  21. Clinical Trials1▲ 7.1×6 topics
  22. Immunotherapy1▲ 6.9×10 topics
  23. Machine Learning1▲ 1.99×2 topics
  24. Targeted Therapy1▲ 21×5 topics
  25. Medical Imaging1▲ 15×1 topic
  26. Oxidative Stress1▲ 2.2×7 topics
  27. Radiomics1▲ 64×1 topic

Which research topics does Abzena (United Kingdom) publish most on?

By volume in 2022–2025: Radiomics and Machine Learning in Medical Imaging, Monoclonal and Polyclonal Antibodies Research, PARP inhibition in cancer therapy and Advanced Biosensing Techniques and Applications.

  1. 1 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 PARP inhibition in cancer therapy Oncology 1 works
  4. 4 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
  5. 5 DNA Repair Mechanisms Molecular Biology 1 works
  6. 6 Advanced Proteomics Techniques and Applications Spectroscopy 0 works
  7. 7 HER2/EGFR in Cancer Research Oncology 0 works
  8. 8 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  9. 9 Quinazolinone synthesis and applications Organic Chemistry 0 works
  10. 10 Microwave-Assisted Synthesis and Applications Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.9%not open67.1%

World: 28% of research is openly available.

with international co-authors57.9%domestic only42.1%

World: 19% is written across borders.

How has Abzena (United Kingdom)'s research output changed?

Output in 2018–2022 was 149% higher than in 2013–2017.

2020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.